scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1049075340 |
P356 | DOI | 10.1097/WOX.0B013E318272484E |
P932 | PMC publication ID | 3651208 |
P698 | PubMed publication ID | 23282336 |
P5875 | ResearchGate publication ID | 234042033 |
P50 | author | Sergio Bonini | Q42220764 |
P2093 | author name string | Sergio Bonini | |
P2860 | cites work | Close collaboration between academia, industry and drug regulators is required in the development of allergen products for specific immunotherapy in children. | Q46020580 |
The EAMG position on the regulation of existing products for treatment with special reference to named patient products (NPPs). | Q52089842 | ||
Allergen immunotherapy: a practice parameter third update. | Q52712682 | ||
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper | Q61684954 | ||
Who benefits from immunotherapy? | Q61685029 | ||
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: a Global Allergy and Asthma European Network (GA(2)LEN) article | Q82636815 | ||
Clinical guidelines: developing guidelines | Q33536430 | ||
The heterogeneity of allergic phenotypes: genetic and environmental interactions | Q34480417 | ||
Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper | Q34754637 | ||
Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. | Q36734980 | ||
The regulatory system in europe with special emphasis on allergen products | Q37224227 | ||
Comparison of allergen immunotherapy practice patterns in the United States and Europe | Q37677729 | ||
Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline | Q37770580 | ||
Regulatory aspects of specific immunotherapy in Europe | Q37791805 | ||
Regulatory environment for allergen-specific immunotherapy | Q37834696 | ||
New perspective and new challenges in clinical trial regulation in Italy. | Q37856610 | ||
Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes | Q37941117 | ||
Perspectives on allergen-specific immunotherapy in childhood: an EAACI position statement | Q38010810 | ||
Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component | Q41034495 | ||
P433 | issue | 10 | |
P921 | main subject | immunotherapy | Q1427096 |
P304 | page(s) | 120-123 | |
P577 | publication date | 2012-10-01 | |
P1433 | published in | The World Allergy Organization Journal | Q15756346 |
P1476 | title | Regulatory aspects of allergen-specific immunotherapy: europe sets the scene for a global approach | |
P478 | volume | 5 |